Preliminary Results

RNS Number : 3611M

Finsbury Food Group PLC

16 September 2019

 

Date:	16 September 2019
On behalf of:	Finsbury Food Group Plc ('Finsbury', 'the Company' or 'the Group')
Embargoed until:       0700hrs

Finsbury Food Group Plc

Preliminary Results

Finsbury Food Group Plc (AIM: FIF), a leading UK speciality bakery manufacturer of cake, bread and morning goods for the retail and foodservice channels, is pleased to announce its preliminary results for the financial year ended 29 June 2019.

Summary

·      Group revenue £315.3m up 3.8%, (up 4.0% on a like for like*¹ basis)  

·      Adjusted*²  EBITDA flat at £25.5m

·      Profit before tax £13.6m up 203%

·      Basic EPS 7.3p up 329%

·      Total dividend increased 6.1% to 3.5p

Strategic highlights

·      Completed the acquisition of Ultrapharm, a manufacturer of Gluten Free Bread and Morning Goods

·      Second half like for like growth 7.5% compares to first half of 0.5%, reflecting significant new business gains

·      Investment in automated individually wrapped cake bar capacity is followed by the successful launch of a new range of cake bars for 'on the go' consumption

·      Significant number of product launches including the new 'Vegan' brioche style burger bun into Foodservice, approved by The Vegan society and a new line of Mary Berry cakes

·      Group wide review of bakery processes is leading to the standardisation of best practice with tangible improvement in quality and consistency and reduction of production waste

·      Award wins include Bakery Manufacturing company of the year and several Quality Food Awards

·      Successful roll out of a new IT platform, across all companies in UK Bakery

·      Introduced Workplace by Facebook across the Group to drive collaboration

The Group uses Alternative Performance Measures (APMs) which are non-IFRS measures to monitor performance of its operations and of the Group as a whole. The reconciliation to IFRS measures is shown in the tables on page 3.

*¹Like for like revenue is the revenue from operations excluding the revenue from the closed bakeries and acquired businesses.

*² Adjusted profit is before significant non-recurring and other items.

Commenting on the results, John Duffy, Chief Executive of Finsbury Food Group Plc, said:

"In what has been a continued challenging market environment, our sales growth and increased dividend demonstrates our ability to navigate more challenging times and our continued confidence in the prospects of the Group. Our achievements have been underpinned by our relentless focus on investment, efficiency and innovation, alongside our ability to harness the growth available from premium, healthy and authentic on-trend innovation.

"We are confident that the Group is on a strong footing and able to drive further growth in the period ahead, as we continue to build a strong, lean, scale competitor and consolidator."  

This announcement contains inside information.

Contact:

Finsbury Food Group                       John Duffy (Chief Executive) Steve Boyd (Finance Director)	www.finsburyfoods.co.uk	029 20 357 500
Cenkos Securities Max Hartley (Corporate Finance)
Alma PR                                          Rebecca Sanders-Hewett Sam Modlin	[e-mail]	020 3405 0205

Notes to editors:

·      Finsbury Food Group Plc (AIM: FIF) is a leading UK manufacturer of cake and bread bakery goods, supplying a broad range of blue chip customers within both the grocery retail and 'out of home eating' foodservice sectors including major multiples and leading foodservice providers.

·      The Company is one of the largest speciality bakery groups in the UK and, with its Overseas division, has sales in the financial year ending 29 June 2019 exceeding £315m.

·      The Company's bakery product range is comprehensive and includes:

o  Large premium and celebration cakes.

o  Small snacking cake formats such as cake slices and bites.

o  Artisan, healthy lifestyle and organic breads through to rolls, muffins (sweet and savoury) and morning pastries, all of which are available both fresh and frozen dependent on customer channel requirements.

o  Gluten Free bread, morning goods and cake ranges.

·      The Company is one of the largest ambient cake manufacturers in the UK, a market valued at over £969 million (source: IRI, 52 w/e 20^th July 2019). The retail bread and morning goods market has a value of £4.5 billion (source: Kantar Worldpanel 52 w/e 14^th July 2019). The retail Free From Cake market is valued at £49.5 million (source: Kantar Worldpanel 52 w/e 24^th March 2019). The retail Free From bread & morning goods market is valued at £125.3 million (source: Kantar Worldpanel 52 w/e 21^st April 2019). The UK Out of Home sector Foodservice Bakery sector is worth approximately £747 million per annum (source: derived from MCA data for 52 weeks to 31^st March 2019). The UK foodservice cake and sweet morning goods bakery sector is worth approximately £918 million per annum (UK foodservice data derived from MCA data for 52 weeks to 31^st March 2019).

·     The Company comprises a core UK Bakery division and an Overseas division:

o  The UK Bakery division has manufacturing sites in Cardiff, East Kilbride, Hamilton, Salisbury, Sheffield, Manchester, and Pontypool.

o  The Overseas division comprises the Company's 50% owned company, Lightbody Stretz Ltd, which supplies and distributes the Group's UK-manufactured products and third party products, primarily to Europe, and the Company's manufacturing facility in Żywiec in Poland.

·      In September 2018, the Company completed the acquisition of Free From baker Ultrapharm, giving the Group a significant opportunity to access an exciting and high growth marketplace and manufacturing facilities in Pontypool in the UK and in Żywiec, Poland.

Adjusted operating profit reconciliation statutory to adjusted.

The figures are for the 52 weeks ended 29 June 2019 and 52 weeks ended 30 June 2018:

Adjusted Operating Profit	2019 £000	2018 £000
Operating profit	15,293	5,237
Significant non-recurring items - SNR (refer to Note 4 for detail)	1,200	13,067
Difference between defined benefit pension scheme charges and cash cost	162	(411)
Movement in the fair value of foreign exchange contracts	178	(49)
Adjustments, SNR and other items	1,540	12,607
Adjusted operating profit	16,833	17,844

Adjusted Profit before Tax	2019 £000	2018 £000
Profit before Tax	13,576	4,475
Significant non-recurring items - SNR (refer to Note 4 for detail)	1,200	13,067
Difference between defined benefit pension scheme charges and cash cost	444	(134)
Movement in the fair value of foreign exchange contracts	178	(49)
Discounting of deferred consideration	139	-
Movement in the fair value of interest rate swaps	382	(143)
Adjustments, SNR and other items	2,343	12,741
Adjusted profit before tax	15,919	17,216

Adjusted operating profit and profit before tax exclude significant and non-recurring and other items as shown in the tables above and includes amortisation of intangibles. The adjusted operating profit has been given as, in the opinion of the Board, this will allow shareholders to gain a clearer understanding of the trading performance of the Group.

The Financial Review Section within the Strategic Report provides further details on the adjusted profits.

Chairman's Statement

This robust performance delivered during the year highlights that our exceptional management team and strategy has again delivered results that significantly outperform the market against a backdrop of consumer malaise, cost inflation and macro uncertainty, which has undermined sentiment in the sector. Our ability to innovate and provide our customers with desirable and quality products is testament to the strength of the Group's creativity, investment and growing operational maturity.

Group revenue increased by 3.8% to £315.3m. Adjusted EBITDA was £25.5m and profit before tax was £13.6 million. We have announced a growth in the dividend which will take the total dividend for the year to 3.5p per share, up 6.1% from last year.

Delivering on our ever-consistent vision

Our vision is to be the leading speciality bakery group, producing a broad range of high-quality products that fulfil the needs and demands of end consumers, delivering a differentiated product for our customers whilst driving growth for the Group, both throughout the UK and Europe.

We continue to build a business of scale, but also one that can deal with the manufacturing complexity and flexibility required for the breadth of ranges we deliver to the foodservice and the retail markets - from specialist, artisan products to premium or higher-margin products. For ten years we've been delivering this while improving efficiency, investing strategically and thoughtfully, whilst reducing debt and improving diversification.

We believe scale will become increasingly important in the food manufacturing sector as we see our main customers getting larger. Over the years we have made major acquisitions and investments, targeting opportunities based on consumer trends, market niches, new channels and added-value products that retail and foodservice customers are trying to develop. As such, we are well positioned to continue to successfully deliver this increasing product range to our larger customers whilst still maintaining strong relationships with our smaller customers.

Illustrating our ability to complete strategic and complementary acquisitions, the acquisition of Ultrapharm has accelerated our access to the high growth Free From market. We have established a robust platform, increased capacity through a new bakery and resourced the business to allow it to have all the key ingredients to drive further growth.

Through a combination of organic growth and targeted acquisitions in what is a very fragmented market, we will continue to invest, consolidate and therefore grow in areas where we believe we can drive the most value, such as artisan bread, Free From and foodservice.

Operational agility delivering results

Our diversification, agility and innovation has allowed the Group to not only adapt but also perform well in the face of the cost pressures and market volatility we have seen of late. We've continued to not only drive efficiency, but at the same time deliver innovation, allowing us to maintain our leading position in the market.

As part of our drive to ensure excellence across the Group, our Operating Principles were launched in the first half of the year, and are now being applied consistently across the Group. This allows us to deliver group wide initiatives to drive scale, productivity and best practice. This will be a major strategic theme over the coming years as we unlock benefits from these investments, including our recent IT roll out across the Group.

Board

The Board is committed to high standards of corporate governance, and has chosen to comply with the QCA Corporate Governance Code. In April we announced that Zoe Morgan, a Non-Executive Director of the Company and Chairman of the Remuneration Committee, would not be seeking renewal of her directorship. I would like to thank Zoe for her valuable contribution over the last three years to both the Board and to the Company. Subsequently, Marnie Millard, a Non-Executive Director of the Company, took over the Chairmanship of the Remuneration Committee from 1st July 2019.

People

Our people are truly the heartbeat of the Group. Over the last few years we have implemented a considerable number of Group wide initiatives to ensure that we really are being the best that we can be. The hard work of our teams on a day-to-day basis and engagement with the new initiatives we have introduced has been truly inspiring. With these projects now materially complete, the Group is focused on harnessing the outcomes of these initiatives to drive productivity. Alongside this, the teams' skill and ability to continuously create products that appeal to our customers is remarkable. I would like to thank them all for their tireless effort and look forward to working together to continue to deliver baking brilliance.

Peter Baker

Non-Executive Chairman

13 September 2019

Chief Executive's Report

Performance review

The Board is pleased to report its full year results, which show strong sales momentum which has continued into the new financial year. The Group has grown sales year on year, driven by organic growth, the Ultrapharm acquisition and previously communicated new business wins, despite the challenging retail environment and unprecedented input cost inflation we have experienced over the period. This robust performance has been delivered with a continuous focus on innovation using our extensive knowledge of our markets and what our end consumers want.

The relentless investment and efficiency focus of recent years has enabled us to navigate this market environment successfully. As we come out of our intense investment phase, with capital expenditure of £11.0m in the period, the Group will continue to benefit from the investments made for years to come. The true measure of success is that we have once again achieved underlying growth ahead of our market and have demonstrated the growth available from premium, healthy and authentic on-trend innovation.

Illustrating this, following the launch of our own Free From brand in Europe last year, Wiso, we have also launched Free From cakes in addition to the comprehensive Free From bread and morning goods ranges. These products capitalise on the fact that making the choice to avoid gluten or embrace veganism are growing lifestyle and health choice across North America, Europe and UK.

The Group's diversification by channel has truly delivered in the period with our 'out of home eating' foodservice market, where we supply pub and restaurant chains, fast-food outlets and contract caterers, being a particularly strong performer. As consumer habits change it is vital that our product offering remains on trend and relevant to our end customers, illustrated by the success of our vegan brioche-style buns.

We continue to have a broad portfolio of licensed brands that are complementary to our retailer own label business and Foodservice range. This offering is vital in meeting consumer trends and expectations with our portfolio evolving all the time. The second half of the year has been particularly active with the big block buster movie releases of Toy Story 4 and the latest Avengers and Spiderman instalments, which have all broken cinematic records and have their own cake range. We also continued to keep our core evergreen product portfolio licenses fresh with a relaunch of our Batman, Minions, Pokemon, Paw Patrol, Peppa Pig, Trolls and Me to You cakes.

Artisan breads, which may be hand-crafted, require long fermentation, baking in stone ovens, and a skilled team, continues to grow strongly. As such, we are looking to invest in further capacity to capitalise on this growing trend, going forward. 

Innovation and craftmanship

Key components of our strategy are creating innovative, high-quality bakery products that anticipate and deliver on key market trends, ensuring customer and consumer needs are at the heart of our decision making. We always strive to be front and centre of these trends and this is driven by our deep knowledge of the markets we serve combined with the skill and experience of our employees. An example of this is the successful launch of a new range of cake bars for on the go consumption which drove our investment in automated individually wrapped cake bar capacity, and the launch of our vegan brioche style bun into Foodservice, which is approved by The Vegan Society. We are constantly listening, monitoring, and testing to make sure that we're on top of trends as they emerge.

Be it foodservice, licensed brands or retailer owned brands - evolving consumer trends such as indulgence, health and wellbeing, or adapting single serve product formats for convenient out of home eating occasions have played a large part in driving the growth in our core division, enabling the Group to perform ahead of the wider market.

Illustrating this ability to deliver innovative, on trend and high-quality products, the Group was delighted to be recognised at the Food Manufacturer Excellence Awards, winning the Bakery Manufacturer of the year. Meanwhile, a number of our products were placed in the winner's category at the Quality Food Awards.

Sitting at the heart of the Group is our ability to innovate and craft products that our customers want to purchase.

Maximising the benefits of the Group's structure

Throughout the last couple of years, a core part of our strategy has been to ensure that all our businesses acknowledge and embrace the key strengths of the Group, whilst benefitting from common approaches. Our newly introduced IT platform has been implemented to support common business processes and further efficiency improvement, and we have also developed our Group-wide people strategy. Now that both of these have been rolled out across the Group, we are starting to see the benefits that this approach is expected to deliver.

We are building a Group-wide Process Blueprint which is standardising processes and practices to improve plant performance and reliability, which of course delivers improved efficiency and quality. We know that there are still aspects that we can further improve and we are in the process of setting up a Group Bakery Efficiency Programme and an Operational Supply Chain Forum, which will continue to drive improvements in quality and consistency, plus further reduce production waste.

All of the initiatives mentioned above are examples of our Operating Principles in action. The Finsbury Operating Principles effectively help to achieve our Purpose and Strategy, creating long‐term shareholder value through share price growth and attractive dividends.

We know that the benefits of utilising our Group structure and expertise will help us to be the leading speciality group that we strive to be.

Strength in collaboration

We are seeing encouraging results from our people strategy throughout the Group. The positive momentum is illustrated by a number of internal promotions into senior roles over the last year. These promotions demonstrate the benefits of this programme, as well as our commitment to growing our people with the business. Employee engagement and communication has been significantly improved with the introduction of Workplace, a collaboration platform, across the Group in the first half. The use of this platform has enabled colleagues to collaborate more effectively across teams, projects, sites and accelerate functional best practice transfer as well as create instant communication opportunities and increase transparency.

I would like to thank all of our employees for the way in which they have embraced and engaged with all the initiatives that we have introduced over the last few years. They have responded brilliantly, and we're very grateful for that. We believe that by working together, we become stronger as a Group.

Broadening our Group through acquisition

In September 2018 we acquired a specialist Free From bakery, Ultrapharm. As with all acquisitions, we completed a comprehensive multi-function assessment, utilising expert resource from across the Group as well as the existing management team, against Group standards and best practice before creating a prioritised integration action plan. Additional expert resources from across the Group have complemented management to implement the year one plan which is now largely complete as expected.

In addition, we have invested in new capacity, with a new bakery in Poland, alongside additional resources and skills to deliver a stronger platform for anticipated future growth.

Whilst we remain committed to future acquisition-led growth as part of our strategy, as always, we are focused on driving organic growth and efficiency within the current Group structure. With any further acquisitions we would be looking to introduce new product, customer or channel diversification, or accelerate market consolidation in our main product areas.

Outlook

We are confident that the strong second half performance will continue into the year ahead, as the core business continues to perform well with strong quarter one growth to date, outperforming Finsbury's respective markets.

We have made a number of significant investments across the Group that have stood us in good stead throughout what has been a more difficult period. With the Group now in its strongest position in recent years and having completed a period of intense investments including the IT platform roll out and the new Free From bakery in Poland, we are expecting to significantly reduce our capital spend going forward as we focus on driving further efficiencies from the new systems and processes and utilise our additional capacity.

Whilst the wider macroeconomic and political environment remains challenging in the UK, our drive for innovation, outperformance of foodservice and our entry in the Free From market provides a strong footing to continue to drive organic growth. Our Group wide drive for efficiency and productivity coupled with the skill of our people provides Finsbury with a backbone to achieve further growth.

By maintaining a longer-term strategic approach, given an uncertain consumer and inflationary cost environment outlook, we are confident that we will continue to build a strong, lean, scale competitor and consolidator.

John Duffy

Chief Executive Officer

13 September 2019

Financial Review

Group revenue for the 52-week period to 29 June 2019 is £315.3 million, 3.8% higher than last year. Like for like Group revenue (excluding the revenue from the closed bakeries and acquired businesses) is, at £301.8 million, up 4.0% or £11.6 million. Growth in continuing revenue is within markets that are seeing value growth with a slight volume decline.

We have stripped significant and non-recurring costs of £1.2m, which primarily relate to acquisition and restructuring costs, as well as a number of other non trading items listed below, out of operating profit, to give adjusted operating profit, which provides a clearer presentation of the underlying trading performance of the Group. Adjusted operating profit at £16.8 million is down 5.7% on last year. Adjusted operating profit margins are 5.3% (2018: 5.9%), a consequence of a challenging global environment. We saw a second half year growth through a combination of organic growth, new business wins, price recovery and the acquisition of Ultrapharm. The Group's performance is seen as resilient attributable to our capital investment, the diversification of the Group into foodservice and high growth areas such as Free From, our constant drive for efficiency and our relentless drive to deliver on customer trends.

Dividend

Subject to shareholder approval at the Company's AGM on 20 November 2019, the final dividend of 2.34 pence per share will be paid on 23 December 2019 to all shareholders on the register at 22 November 2019, and will be recognised in the year ending 27 June 2020.

The tables below show what the Directors consider to be the underlying performance of the Group. The adjustments eliminate the impact of significant and non-recurring items and other accounting items that do not reflect the underlying performance of the Group.

52 week period ended 29 June 2019

	Operating performance	Significant non-recurring items	Defined benefit pension scheme	Fair value of interest rate swaps/ foreign exchange contracts	Discounting of deferred consideration	As per Consolidated Statement of Comprehensive Income
	£000	£000	£000	£000	£000	£000
Revenue	315,281	-	-	-	-	315,281
Cost of sales	(219,849)	-	-	-	-	(219,849)
Gross profit	95,432	-	-	-	-	95,432
Other costs excluding depreciation & amortisation	(69,905)	(1,200)	(162)	(178)	-	(71,445)
EBITDA	25,527	(1,200)	(162)	(178)	-	23,987
Depreciation & amortisation	(8,694)	-	-	-	-	(8,694)
Operating Profit	16,833	(1,200)	(162)	(178)	-	15,293
Finance income	77	-	-	-	-	77
Finance costs	(991)	-	(282)	(382)	(139)	(1,794)
Profit before tax	15,919	(1,200)	(444)	(560)	(139)	13,576
Taxation	(3,605)	128	75	95	24	(3,283)
Profit for the year	12,314	(1,072)	(369)	(465)	(115)	10,293

52 week period ended 30 June 2018

	Operating performance	Significant non-recurring items		Defined benefit pension scheme	Fair value of interest rate swaps/ foreign exchange contracts	As per Consolidated Statement of Comprehensive Income
	£000	£000		£000	£000	£000
Revenue	303,600	-		-	-	303,600
Cost of sales	(211,511)	-		-	-	(211,511)
Gross profit	92,089	-		-	-	92,089
Other costs excluding depreciation & amortisation	(66,489)	(13,067)		411	49	(79,096)
EBITDA	25,600	(13,067)		411	49	12,993
Depreciation & amortisation	(7,756)	-		-	-	(7,756)
Operating profit	17,844	(13,067)		411	49	5,237
Finance income	24	-		-	143	167
Finance costs	(652)	-		(277)	-	(929)
Profit before tax	17,216	(13,067)		134	192	4,475
Share of losses of equity accounted investees after tax	-	-		-	-	-
Taxation	(3,708)	2,452		(23)	(32)	(1,311)
Profit for the year	13,508	(10,615)		111	160	3,164

Earnings per Share (EPS)

EPS comparatives to the prior year can be distorted by significant non-recurring items and other items highlighted above. The Board is focused on growing adjusted diluted EPS which is calculated by eliminating the impact of the items highlighted above as well as amortisation of intangibles and incorporates the dilutive effect of share options.  Adjusted diluted EPS is 9.0p (2018: 9.8p).  

	52 week 2019	52 week 2018
Basic EPS	7.3p	1.7p
Adjusted basic EPS	9.3p	10.2p
Diluted** basic EPS	7.0p	1.6p
Adjusted* diluted** EPS	9.0p	9.8p

*Further details on adjustments can be found in Note 7.

**Diluted EPS takes basic EPS and incorporates the dilutive effect of share options.

Cash Flow

There was an increase in our working capital of £5.6 million (2018: £1.3 million decrease) in the financial year. Corporation Tax payments made in the financial year totalled £2.0 million (2018: £3.3 million). The payments in the current and prior year took account of the research and development tax relief due to the Group, tax losses being utilised, and a higher tax rate charged on overseas profits. Capital expenditure in the year amounted to £11.0 million (2018: £12.6 million).

Debt and Bank Facilities

The Group's total net debt is £35.6 million (2018: £15.6 million), up £20.0 million from the prior year. During the year, the Group acquired Ultrapharm for an initial consideration of £16.9m. The Group has a revolving credit facility available until February 2023 of £55.0 million provided by a club of three banks - HSBC, Rabobank and RBS, with scope for it to be increased by up to a further £35.0 million.

The Group is able to offer strong asset backing to secure its borrowings. The Group owns freehold sites in Cardiff, Sheffield and Scotland. In addition, the Group has a strong trade debtor book made up primarily of the UK's major multiple retailers. This debtor book stood at £45.2 million (2018: £40.0 million) at the period-end date.

The Group recognises the inherent risk from interest rate rises, and uses interest rate swaps to mitigate these risks. The Group has two swaps, one for £20.0 million for five years from 3 July 2017 (fixed) at 0.455% and one for £5.0 million for three years from 28 March 2019 (fixed) at 1.002%. The total balance of swaps at 29 June 2019 is £25.0 million (2018: £20.0 million). The counterparty to these transactions is HSBC Bank Plc.

The effective interest rate for the Group at the year end, taking account of the interest rate swap in place with base rate at 0.750% and LIBOR at 0.715%, was 2.047% (2018: base rate 0.500%and LIBOR 0.501% effective interest rate 1.66%).

Financial Covenants

The Board reviews the Group's cash flow forecasts and key covenants regularly, to ensure it has adequate facilities to cover its trading and banking requirements with an appropriate level of headroom. The forecasts are based on management's best estimates of future trading. There has been no breach of covenants during the year and the Board do not expect any in the forecast periods.

Interest cover (based on adjusted earnings before interest, tax, depreciation and amortisation - EBITDA) for the 52 weeks to 29 June 2019 was 28.0 (2018: 40.7). Net bank debt to EBITDA (based on adjusted EBITDA) for the year to 29 June 2019 was 1.4 (2018: 0.6).

Taxation

The Group taxation charge for the year was £3.3million (2018: £1.3 million). This represents an effective rate of 22.6% on profits before significant and non-recurring and other items (2018: 21.5%). You can find further details on the tax charge in Note 6 to the Group's Financial Statements.

Financial and Non-Financial Key Performance Indicators

We monitor a range of financial and non-financial KPIs at site level covering, amongst others, productivity, quality and health and safety. The Group Board receives a regular overview of all KPIs. 

The Strategic Report was approved by the Board of Directors on 13 September 2019 and was signed on its behalf by:

Stephen Boyd

Director

Consolidated Statement of Comprehensive Income

for the 52 weeks ended 29 June 2019 and 52 weeks ended 30 June 2018

			2019	2018
		Note	£000	£000
Revenue		2	315,281	303,600
Cost of sales			(219,849)	(211,511)
Gross profit			95,432	92,089
Administrative expenses - underlying		3	(78,939)	(73,785)
Administrative expenses - significant and non-recurring		4	(1,200)	(13,067)
Operating profit			15,293	5,237
Finance income		5	77	167
Finance cost		5	(1,794)	(929)
Net finance cost			(1,717)	(762)
Profit before tax			13,576	4,475
Taxation		6	(3,283)	(1,311)
Profit for the financial year			10,293	3,164
Other comprehensive (expense)/income
Items that will not be reclassified to profit and loss
Remeasurement on defined benefit pension scheme			(332)	(172)
Movement in deferred taxation on pension scheme liability			56	29
Other comprehensive expense for the financial year, net of tax			(276)	(143)
Total comprehensive income for the financial year			10,017	3,021
Profit attributable to:
Equity holders of the parent			9,287	2,180
Non-controlling interest			1,006	984
Profit for the financial year			10,293	3,164
Total comprehensive income attributable to:
Equity holders of the parent			9,011	2,037
Non-controlling interest			1,006	984
Total comprehensive income for the financial year			10,017	3,021
Earnings per ordinary share
Basic		7	7.3	1.7
Diluted		7	7.0	1.6

Consolidated Statement of Financial Position

 at 29 June 2019 and 30 June 2018                                                                                                                                

	Note	2019	Restated 2018
		£000	£000
Non-current assets
Intangibles	8	97,664	83,313
Property, plant and equipment		57,009	49,922
Investments in equity accounted investees		-	-
Other financial assets		28	28
Deferred tax assets		3,655	3,890
		158,356	137,153
Current assets
Inventories		14,805	13,456
Trade and other receivables		49,724	44,575
Cash and cash equivalents		12,358	9,363
Other financial assets - fair value of derivatives		176	558
		77,063	67,952
Total assets		235,419	205,105
Current liabilities
Other interest-bearing loans and borrowings	9	(335)	-
Trade and other payables		(55,543)	(55,598)
Provisions		(2,640)	(3,798)
Other financial liabilities - fair value of derivatives		(218)	(40)
Deferred consideration		(1,000)	-
Current tax liabilities		(306)	-
		(60,042)	(59,436)
Non-current liabilities
Other interest-bearing loans and borrowings	9	(47,390)	(24,685)
Provisions		(3,434)	(4,623)
Deferred consideration		(1,824)	-
Deferred tax liabilities		(1,800)	(1,243)
Pension fund liability		(11,312)	(10,536)
		(65,760)	(41,087)
Total liabilities		(125,802)	(100,523)
Net assets		109,617	104,582
Equity attributable to equity holders of the parent
Share capital		1,304	1,304
Share premium account		64,956	64,956
Capital redemption reserve		578	578
Employee share reserve		(3,616)	(3,282)
Retained earnings		44,207	38,954
		107,429	102,510
Non-controlling interest		2,188	2,072
Total equity		109,617	104,582

In the prior year accounts, £24,685,000 was presented as "Current liability - Other interest-bearing loans and borrowings". This has been restated to "Non-current liabilities - Other interest-bearing loans and borrowings". Refer also to "Basis of preparation" note.

These Financial Statements were approved by the Board of Directors on 13 September 2019 and were signed on its behalf by:

Stephen Boyd (Director)      

Registered Number 00204368

The Notes on pages 15 to 23 form an integral part of these Financial Statements.

Consolidated Statement of Changes in Equity

for the 52 weeks ended 29 June 2019 and 30 June 2018

				Share Capital		Share premium		Capital redemption reserve		Employee share reserve		Retained Earnings		Non-controlling interest		Total equity
				£000		£000		£000		£000		£000		£000		£000
Balance at 1 July 2017				1,304		64,956		578		(3,585)		39,862		1,887		105,002
Profit for the financial year				-		-		-		-		2,180		984		3,164
Other comprehensive (expense)/ income:
Remeasurement on defined benefit pension				-		-		-		-		(172)		-		(172)
Deferred tax movement on pension scheme remeasurement				-		-		-		-		29		-		29
Total other comprehensive expense				-		-		-		-		(143)		-		(143)
Total comprehensive income for the period				-		-		-		-		2,037		984		3,021
Transactions with owners, recorded directly in equity:
Shares issued from EBT				-		-		-		303		(217)		-		86
Impact of share-based payments				-		-		-		-		1,138		-		1,138
Deferred tax on share options				-		-		-		-		58		-		58
Foreign exchange translation differences				-		-		-		-		34		-		34
Dividend paid				-		-		-		-		(3,958)		(799)		(4,757)
Balance at 30 June 2018				1,304		64,956		578		(3,282)		38,954		2,072		104,582
Balance at 30 June 2018				1,304		64,956		578		(3,282)		38,954		2,072		104,582
Profit for the financial year				-		-		-		-		9,287		1,006		10,293
Other comprehensive (expense)/ income:
Remeasurement on defined benefit pension				-		-		-		-		(332)		-		(332)
Deferred tax movement on pension scheme remeasurement				-		-		-		-		56		-		56
Total other comprehensive expense				-		-		-		-		(276)		-		(276)
Total comprehensive income for the period				-		-		-		-		9,011		`1,006		10,017
Transactions with owners, recorded directly in equity:
Shares issued from EBT				-		-		-		(499)		-		-		(499)
Shares issued during the year				-		-		-		165		(165)		-		-
Impact of share-based payments				-		-		-		-		696		-		696
Deferred tax on share options				-		-		-		-		(256)		-		(256)
Foreign exchange translation differences				-		-		-		-		250		-		250
Dividend paid				-		-		-		-		(4,283)		(890)		(5,173)
Balance at 29 June 2019				1,304		64,956		578		(3,616)		44,207		2,188		109,617
The notes on pages 15 to 23 form an integral part of these Financial Statements.

Consolidated Cash Flow Statement

for the 52 weeks ended 29 June 2019 and 30 June 2018     

	Note	2019	2018
		£000	£000
Cash flows from operating activities
Profit for the financial year		10,293	3,164
Adjustments for:
Taxation	6	3,283	1,311
Net finance costs	5	1,717	762
Depreciation		7,366	7,041
Amortisation of intangibles	8	1,328	715
Significant non-recurring items	4	1,200	13,067
Contributions by employer to pension scheme		162	(411)
Change in fair value of foreign exchange contracts		178	(49)
Operating profit before changes in working capital		25,527	25,600
Changes in working capital:
Increase in inventories		(62)	(757)
(Increase)/decrease in trade and other receivables		(3,321)	6,235
Decrease in trade and other payables		(2,199)	(4,160)
Cash generated from operations before costs of disposals and acquisitions		19,945	26,918
Costs relating to closure of bakeries and acquisitions		(3,534)	(4,594)
Interest paid		(856)	(634)
Tax paid		(2,040)	(3,338)
Net cash generated from operating activities		13,515	18,352
Cash flows from investing/divesting activities
Purchase of property, plant and equipment and intangibles		(11,016)	(12,606)
Disposal of property, plant and equipment		-	768
Purchase of companies	1	(16,915)	-
Net cash used in investing activities		(27,931)	(11,838)
Cash flows from financing activities
Repayment of invoice discounting	10	-	(11,646)
Drawdown/(Repayment) of revolving credit	10	22,144	25,000
Repayment of mortgage and bank loans	10	-	(8,794)
Drawdown/(Repayment) of asset finance liabilities	10	828	(57)
Options exercised/(purchase) of shares by employee benefit trust		(499)	86
Dividend paid to non-controlling interest		(890)	(799)
Dividend paid to shareholders		(4,283)	(3,958)
Net cash generated from / (used in) financing activities		17,300	(168)
Net increase in cash and cash equivalents		2,884	6,346
Opening cash and cash equivalents		9,363	3,024
Effect of exchange rate fluctuations on cash held		111	(7)
Cash and cash equivalents at end of period		12,358	9,363
The Notes on pages 15 to 23 form an integral part of these Financial Statements.

 

Presentation of Financial Statements

Basis of Preparation

Background

The financial information on pages 11 to 14 is extracted from the Group's consolidated financial statements for the 52 week period ended 29 June 2019, which were approved by the Board of Directors on 13 September 2019.

The financial information does not constitute statutory accounts within the meaning of sections 434(3) and 435(3) of the Companies Act 2006 or contain sufficient information to comply with the disclosure requirements of International Financial Reporting Standards (IFRS) and related interpretations as adopted for use in the European Union.

The Company's auditors, PricewaterhouseCoopers LLP, have given an unqualified report on the consolidated financial statements for the 52 week period ended 29 June 2019. The auditors' report did not include reference to any matters to which the auditors drew attention without qualifying their report and did not contain any statement under section 498 of the Companies Act 2006. The consolidated financial statements will be filed with the Registrar of Companies, subject to their approval by the Company's shareholders on 20 November 2019 at the Company's Annual General Meeting.

Basis of accounting

The Group's consolidated financial statements for the year ended 29 June 2019 have been prepared in accordance with International Financial Reporting Standards (IFRS) and related interpretations as adopted for use in the European Union and those parts of the Companies Act 2006 that are applicable to companies reporting under IFRS.

The Directors are satisfied that the Group has adequate resources to continue to operate for a period of not less than 12 months from the date of approval of the financial statements and that there are no material uncertainties around their assessment. Accordingly, the Directors continue to adopt the going concern basis of accounting.

The Group's principal accounting policies have been consistently applied throughout the year and will be set out in the notes to the Group's 2019 Annual Report.

Restatement of prior year comparatives

The prior year comparatives in the consolidated financial statements have been restated to reflect the following prior year adjustments:

The Other interest-bearing loans and borrowings within current liabilities has been reduced by £24.7m and the Other interest-bearing loans and borrowings within Non-current liabilities has been increased by £24.7m to reflect the appropriate classification of the Group's Revolving Credit Facility which has a maturity date of February 2023. This adjustment does not impact any other primary financial statement.

Accounting standards adopted during the year

In the current year, the Group has adopted, with effect from 1 July 2018, the following new accounting standards:

- IFRS 9 Financial instruments

- IFRS 15 Revenue from contracts with customers

In accordance with the transitional provisions in IFRS 9 and IFRS 15 comparative figures have not been restated. The adoption of these new standards has not had a material effect on the Group's financial statements.

Accounting standards issued but not yet adopted

IFRS 16 "Leases" is effective for accounting periods commencing on or after 1 January 2019. The Group will apply the standard for the first time for the year ending 27 June 2020. IFRS 16 represents a fundamental change in lease accounting for lessees, because, with the exception of leases of less than 12 months duration and leases of low value assets, all leases are brought on balance sheet. The impact of this, had the Group applied IFRS 16 for the year ended 29 June 2019, is considered to have an immaterial impact on profit before tax whilst increasing EBITDA by approximately £3-£4 million for the year ending 29 June 2019. Both Assets and Liabilities are expected to increase by £11-£12 million on adoption as at 29 June 2019 with an immaterial impact to Total Net Assets.

No other new standards, new interpretations or amendments to standards or interpretations have been published which are expected to have a significant impact on the Group's financial statements.

1.         Acquisition

On 3 September 2018 the Group acquired the entire share capital of Ultrapharm Limited (Ultrapharm) for £16.9 million plus up to £3 million payable in annual instalments to the period to 30 June 2021 and a final incentive payment subject to performance criteria over the period to 30 June 2021. No provision has been made for a final incentive payment as the criteria are not currently expected to be met. As a specialist 'Free From' bakery, the business has an extensive product range including bread, buns & rolls and other morning goods. Ultrapharm has a diverse customer base with long term blue-chip customers, including Finsbury itself, where it supplies Free From products to Lightbody Europe.

The cash outflow under 'purchase of companies' of £16,915,000 on the face of the Consolidated Cash Flow Statement in the 52 weeks ended 29 June 2019 relates to the following:

	£000
Initial consideration	14,869
Debt settled	2,792
Cash acquired	(746)
Cash consideration (excluding acquisition costs)	16,915
Working capital adjustment	(60)
Discounted deferred consideration net of deferred taxation	2,737
Total consideration including working capital adjustment	19,592

The acquisition had the following effect on the Group's assets and liabilities:

	Fair value and book value £000
Acquiree's net assets at acquisition date:
Property, plant and equipment	5,766
Stock	1,200
Trade and other receivables	2,392
Deferred tax liability	(381)
Trade and other payables	(2,652)
Net identifiable assets	6,325
Intangible	1,721
Goodwill	11,546
	19,592

The post-acquisition revenue included within these financial results amounts to £15,690,000 (including £2,584,000 of inter-company sales) and an operating profit of £295,000.

2.             Revenue and Segment Information

Operating segments are identified on the basis of the internal reporting and decision making. The Group's Chief Operating Decision Maker is deemed to be the Board as it is primarily responsible for the allocation of resources to segments and the assessment of performance by segment. The Board assesses profit performance principally through adjusted profit measures consistent with those disclosed in the Annual Report and Accounts.

The UK Bakery segment manufactures and sells bakery products to UK grocery and food service sectors. It comprises six subsidiaries all of which manufacture and supply food products through the channels described above. These subsidiaries have been aggregated into one reportable segment as they share similar economic characteristics. The economic indicators considered are the nature of the products and production process, the type and class of customer, the method of distribution and the regulatory environment.

The Overseas segment procures and sells bakery products to European grocery and food service sectors. It comprises Lightbody Europe and Ultraeuropa. Ultraeuropa has manufacturing facilities in Poland where it manufactures and sells Free From bakery products into the European markets.

The Company acquired Ultrapharm on 3 September 2018, the prior year financial results include those relating to the closed bakeries, the table below shows the acquired revenue net of inter-company sales and the like for like revenue.

Revenue	UK Bakery		Overseas			Total Group
52 weeks to 29 June 2019 and 52 weeks to 30 June 2018.	2019 £000	2018 £000	2019 £000	2018 £000	2019 £000		2018 £000
Total	278,533	271,127	36,748	32,473	315,281		303,600
From acquired business	8,239	-	4,867	-	13,106		-
From closed business	336	13,354	-	-	336		13,354
Like for like	269,958	257,773	31,881	32,473	301,839		290,246

Reportable Segments	52 weeks to 29 June 2019 £000 Total	52 weeks to 30 June 2018 £000 Total
Revenue UK Bakery	278,533	271,127
Revenue Overseas	36,748	32,473
Total revenue	315,281	303,600
Adjusted operating profit UK Bakery	14,180	15,496
Adjusted operating profit Overseas	2,653	2,348
Total adjusted operating profit	16,833	17,844
Significant non-recurring and other items	(1,200)	(13,067)
Defined benefit pension scheme	(162)	411
Fair value foreign exchange contracts	(178)	49
Operating profit	15,293	5,237
Finance income	77	167
Finance expense	(1,794)	(929)
Net finance cost	(1,717)	(762)
Profit before taxation	13,576	4,475
Taxation	(3,283)	(1,311)
Profit for the financial year	10,293	3,164

The Group has three customers (2018: three) which individually account for 10 per cent or more of the Group's total revenue. These customers individually account for 19 per cent, 12 per cent and 10 per cent. In the prior year these same three customers accounted for 20 per cent, 13 per cent and 10 per cent of the revenue in the 52 weeks to 30 June 2018. In addition to the Europe sales disclosed in Reportable Segments, the Group also made sales to European markets through UK-based organisations.

3.     Administrative Expenses and Auditors' Remuneration

Included in profit are the following:

	2019	2018
	£000	£000
Amortisation of intangibles	1,328	715
Depreciation of owned tangible assets	7,072	6,859
Depreciation on assets under finance leases and hire purchase contracts	294	182
Impairment of assets & goodwill	-	987
Loss on foreign exchange	166	260
Hire of plant and machinery - operating leases	765	797
Hire of other assets - operating leases	806	1,302
Movement on fair value of foreign exchange contracts	178	(49)
Research and development	1,987	1,567
Share option charges	697	1,138
Government grants	-	25

Auditors' remuneration:

	2019	2018
	£000	£000
Audit of these Financial Statements	60	60
Amounts receivable by the auditors and its associates in respect of:
Audit of the Financial Statements of subsidiaries of the Company	133	120
Taxation compliance services	-	24
Other tax advisory	-	10
Other services	-	173
The auditors' remuneration for the current year is in respect of PricewaterhouseCoopers LLP and is in respect of KPMG LLP in the prior year with fees for other services relates to pension advisory services and services relating to information technology.

4.     Significant Non-Recurring Items

The Group presents certain items as significant and non-recurring. These relates to items which, in management's judgement, need to be disclosed by virtue of their size or incidence in order to obtain a more meaningful understanding of the financial information. They reflect costs that will not be repeated and therefore do not reflect ongoing trading of business which is most meaningful to users.

Included within significant non-recurring items shown in the table In the Financial Review section on page 8 are the following costs:

	2019	2018
	£000	£000
Site closures - reorganisation people costs	-	2,266
Site closures - property, leases and contract costs	(152)	9,604
Site closures - legal and professional costs	-	121
Other reorganisation people costs	823	-
Impairment of assets and investments	-	373
Acquisition related costs	529	703
	1,200	13,067

The site closure provision relates primarily to the closure of the Grain D'Or site during the prior year.

5.     Finance Income and Cost

Recognised in the Consolidated Statement of Comprehensive Income

	2019	2018
	£000	£000
Finance income
Change in fair value of interest rate swaps	-	143
Interest on interest rate swap agreements	60	18
Bank interest receivable	17	6
Total finance income	77	167
Finance cost
Interest on net pension position	(282)	(277)
Change in fair value of interest rate swaps	(382)	-
Bank interest payable	(1,130)	(638)
Interest on interest rate swap agreements	-	(14)
Total finance cost	(1,794)	(929)

6.     Taxation

Recognised in the Consolidated Statement of Comprehensive Income

		2019 £000	2018 £000
Current tax
Current year		2,969	1,236
Adjustments for prior years		194	(93)
Total current tax		3,163	1,143
Deferred tax
Origination and reversal of temporary differences		136	328
Adjustments for prior years		(16)	(160)
Total deferred tax		120	168
Total tax expense		3,283	1,311

Reconciliation of effective tax rate

The weighted average hybrid rate of UK, Polish and French tax is 21.4% (2018: 22.5%). The tax assessed for the period is higher (2018: higher) than the hybrid rate of UK and French tax. The UK corporation tax rate for the period is 19.0% (2018: 19.0%). The differences are explained below:

	2019	2018
	£000	£000
Profit before taxation before losses from equity accounted investees	13,576	4,475
Tax using the UK corporation tax rate of 19.00%, (2018: 19.00%)	2,579	850
Overseas profits charged at different taxation rate	481	277
Non-deductible expenses	195	586
Restatement of opening net deferred tax due to rate change and differences in rates	(60)	(49)
R&D uplift current year	(90)	(100)
Adjustments to tax charge in respect of prior periods	178	(253)
Tax expense (excluding prior year disallowable impairment)	3,283	1,311

The UK corporation tax rate reductions from 20% to 19% from 1 April 2017 and 18% from 1 April 2020 were substantively enacted on 26 October 2015. An additional reduction to 17% from 1 April 2020 was substantively enacted on 6 September 2016. The deferred tax assets and liabilities at 29 June 2019 have been calculated based on these rates.

The adjustment of £178,000 for prior year includes ineligible capital spends offset and disallowable expenses being different to the assumed levels at the time of preparation of the Annual Report.

The Company has an unrecognised deferred tax asset of £162,605 (2018: £162,605) relating to capital losses carried forward. This asset has not been recognised in the financial statements as it is not expected that suitable gains will arise in the future in order to utilise the underlying capital losses.

7.     Earnings Per Ordinary Share

Basic earnings per share for the period is calculated on the basis of profit for the year after tax, divided by the weighted average number of shares in issue being 127,511,000 (2018: 127,611,000). 

Basic diluted earnings per share is calculated by adjusting the weighted average number of ordinary shares in issue to assume conversion of all potential dilutive ordinary shares. At 29 June 2019, the diluted weighted average number of shares in issue was 131,889,000, (2018: 132,162,000).

An adjusted earnings per share has been calculated to show the trading performance of the Group. These adjusted earnings per share exclude:

·      Reorganisation and other significant non-recurring items

·      IAS 39 'Financial Instruments: Recognition and Measurement' fair value adjustment relating to the Group's interest rate swaps and foreign exchange contracts

·      IAS 19 (revised) 'Accounting for retirement benefits' relating to net income

·      The taxation effect at the appropriate rate on adjustments

·      Amortisation of intangible assets

	52 weeks to 29 June 2019		52 weeks to 30 June 2018
Profit	£000		£000
Profit attributable to equity holders of Company (basic)	9,287		2,180
Significant non-recurring and other items	2,021		10,344
Intangible amortisation net of deferred tax	564		446
Numerator for adjusted earnings per share calculation (adjusted basic)	11,872		12,970
Shares	Basic	Diluted	Basic	Diluted
Weighted average number of ordinary shares in issue during the period	'000 127,511	'000 127,511	'000 127,611	'000 127,611
Dilutive effect of share options	-	4,378	-	4,551
	127,511	131,889	127,611	132,162
Earnings per share (pence per share)
Basic and diluted	7.3	7.0	1.7	1.6
Adjusted basic and adjusted diluted	9.3	9.0	10.2	9.8

Significant non-recurring and other items net of taxation are tabled in the Financial Review section on page 8 and comprise: significant non-recurring charges £1,072,000 (2018: £10,615,000), defined benefit pension scheme charge £369,000 (2018: income £111,000) and fair value of interest rate swaps, foreign exchange contracts charge £465,000 (2018: £160,000 income) and the unwinding of deferred consideration discounting charge £115,000 (2018: nil).

8.     Intangibles

Intangible assets comprise customer relationships, brands and goodwill.

 

	Goodwill	Business systems	Brands and licences	Customer relationships	Total
	£000	£000	£000	£000	£000
Cost at 1 July 2017	73,458	3,843	3,683	5,909	86,893
Additions	-	3,726	-	-	3,726
Cost at 30 June 2018	73,458	7,569	3,683	5,909	90,619
Acquired	11,546	-	-	1,721	13,267
Additions	-	2,412	-	-	2,412
Cost at 29 June 2019	85,004	9,981	3,683	7,630	106,298
Accumulated amortisation at 1 July 2017	(4,290)	-	(1,216)	(1,085)	(6,591)
Charge for the year	-	(178)	(143)	(394)	(715)
Accumulated amortisation at 30 June 2018	(4,290)	(178)	(1,359)	(1,479)	(7,306)
Charge for the year	-	(648)	(143)	(537)	(1,328)
Accumulated amortisation at 29 June 2019	(4,290)	(826)	(1,502)	(2,016)	(8,634)
Net book value at 1 July 2017	69,168	3,843	2,467	4,824	80,302
Net book value at 30 June 2018	69,168	7,391	2,324	4,430	83,313
Net book value at 29 June 2019	80,714	9,155	2,181	5,614	97,664

The customer relationships acquired during the year were purchased as part of the Ultrapharm acquisition, those recognised in the opening costs were purchased as part of the acquisition of Fletchers Group of Bakeries in October 2014. They are considered to have finite useful lives and are amortised on a straight-line basis over their estimated useful lives of twenty years for brands and between ten and fifteen years for customer relationships. The intangibles were valued using an income approach, using multi-period excess earnings method for customer relationships and Relief from Royalty Method for brand valuation.  The amortisation of intangibles has been charged to administrative expenses in the Income Statement. The business systems are considered to have finite useful lives and are amortised on a straight-line basis over their estimated useful lives of ten years.

Goodwill has arisen on acquisitions and reflects the future economic benefits arising from assets that are not capable of being identified individually and recognised as separate assets. The goodwill reflects the anticipated profitability and synergistic benefits arising from the enlarged Group structure. The goodwill is the balance of the total consideration less fair value of assets acquired and identified. The carrying value of the goodwill is reviewed annually for impairment. The carrying value of all goodwill has been assessed during the year.

The Group tests goodwill for impairment on an annual basis, or more frequently if there are indications that the goodwill may be impaired. The recoverable amounts of the cash generating units are determined from value in use calculations.  The key assumptions for the value in use calculations are the discount and growth rates used for future cash flows and the anticipated future changes in revenue, direct costs and indirect costs. The assumptions used reflect the past experience of management and future expectations.

The Group prepares cash flow forecasts covering a three-year period based on the detailed financial forecasts approved by management for the next three years. The cashflows beyond this forecast are extrapolated to perpetuity using a 0.5% (2018: nil) growth rate on a prudent, when compared to long term UK GDP, basis, to reflect the uncertainties of forecasting further than three years. Changes in revenue and direct costs in the detailed three year plan are based on past experience and expectations of future changes in the market.  The revenue growth rate combines volume, mix and price of products. An inflation factor has been applied to costs of sales, variable costs and indirect costs and takes into consideration the general rate of inflation, movements in commodities, improvement in efficiencies from capital investment and operations and purchasing initiatives.

A pre-tax discount rate of 11% (2018: 10%) has been used in these calculations. The Group has considered the economic environment and higher level of return expected by equity holders due to the perceived risk in equity markets when selecting the discount rate. The discount rate used for each cash generating unit has been kept constant as the market risk is deemed not to be materially different between the different segments of the bakery sector, nor over time.

The carrying amount of goodwill has been allocated to cash generating units or groups of cash generating units as follows:

	2019 £000		2018 £000
	£000		£000
Lightbody of Hamilton	45,698		45,698
Fletchers Bakery	20,118		20,118
Ultrapharm	11,546		-
Nicholas & Harris	2,980		2,980
Johnstone's Food Service	372		372
	80,714		69,168

Sensitivity analyses have been carried out by the Directors on the carrying value of all remaining goodwill using pre-tax discount rates ranging between 8.0% and 12.5% which would not result in an impairment of any cash generating units.  The table below illustrates the discount rate that would need to be applied for there to be zero headroom when comparing discounted cashflows against carrying amount of goodwill.

	Discount rate
Lightbody of Hamilton	18.8%
Fletchers Bakery	15.0%
Nicholas & Harris	45.9%
Johnstone's Food Service	83.5%

Further sensitivity analysis has been carried out using a range of factors such as growth rate and cost increases. These include:

·      If future growth rate assumption of 0.5% was replaced with zero growth rate

·      If future growth rate assumption of 0.5% was replaced with a decline of 2%

In addition, the Group has a cross-functional team which has prepared a number of strategies to minimise the impact of Brexit. We buy some commodities from Europe. Any tariffs on trade will therefore have a bearing on the Group. We have contingency planning in place, looking at alternative UK sources of products. Higher logistics and administration costs may result from border delays and could necessitate higher stock levels. We are developing labour strategies to retain and develop existing workers, attract and hire new workers and reduce labour, while boosting productivity with our capital investment program. We believe we have strategies that would minimise the impact and the directors are satisfied with the carrying value of the cash generating units.

During the year the Group acquired a specialist Free From bakery, Ultrapharm. As part of the due diligence process a comprehensive multi-function assessment was completed, utilising expert resource from across the Group as well as the existing management team against Finsbury Group standards and best practice before creating a prioritised integration action plan. Additional expert resources from across the Group have complemented management to implement the year one plan which is largely complete. Ultrapharm has been tested for impairment during the reporting period and the directors are satisfied with the carrying value of the cash generating units.

9.     Other Interest-Bearing Loans and Borrowings

This note provides information about the contractual terms and repayment terms of the Group's interest-bearing loans and borrowings, which are measured at amortised cost, using the effective interest rate method. 

2019	Margin	Frequency of Repayments	Year of maturity	Facility £000	Drawn £000	Current £000	Non-Current £000
Revolving credit	1.50%/LIBOR	Varies	2023	55,000	47,144	-	47,144
Finance Lease	Various	Monthly	2023	828	828	335	493
Unamortised transaction costs					(247)	-	(247)
					47,725	335	47,390
Restated 2018	Margin	Frequency of Repayments	Year of maturity	Facility £000	Drawn £000	Current £000	Non-Current £000
Revolving credit	1.30%/LIBOR	Varies	2023	45,000	25,000	-	25,000
Unamortised transaction costs					(315)	-	(315)
					24,685	-	24,685

In the prior year accounts, the Revolving Credit facility and unamortised transaction costs of £24,685,000 were disclosed as "Current".  Refer also to "Basis of preparation" note.

Finance lease liabilities are payable as follows:

		2019			2018
	Minimum lease payments	Interest	Principal	Minimum lease payments	Interest	Principal
	£000	£000	£000	£000	£000	£000
Less than one year	380	45	335	-	-	-
Between one and five years	548	55	493	-	-	-
	928	100	828	-	-	-

All of the above loans are denoted in pounds Sterling, with various interest rates and maturity dates. The main purpose of the above facilities is to finance the Group's operations.

As part of the bank borrowing facility the Group needs to meet certain covenants every six months. There were no breaches of covenants during the year. The covenant tests required are net bank debt: EBITDA, interest cover, debt service cover and capital expenditure.

The revolving credit bank facility available for drawdown is £55 million plus a further £35 million accordion facility (2018: £45 million plus a further £45 million accordion).  At the period end date, the facility utilised was £47.1 million (2018: £25.0 million), giving £7.9 million (2018: £20.0 million) headroom plus a further £35 million (2018: £45 million) accordion.

10.  Analysis of Net Debt

		Restated At year ended 30 June 2018 £000		Cash flow £000		At year ended 29 June 2019 £000
Cash and cash equivalents		9,363		2,995		12,358
Debt due within one year		-		-		-
Debt due after one year		(25,000)		(22,144)		(47,144)
Hire purchase obligations due within one year		-		(335)		(335)
Hire purchase obligations due after one year		-		(493)		(493)
Total net bank debt		(15,637)		(19,977)		(35,614)
Debt		(24,685)		(23,040)		(47,725)
Cash and cash equivalents		9,363		2,995		12,358
Unamortised transaction costs		(315)		68		(247)
Total net bank debt		(15,637)		(19,977)		(35,614)
Cash and cash equivalents		9,363		2,995		12,358
Total debt payable excluding cash		(25,000)		(22,972)		(47,972)

In the prior year accounts, the Debt and transaction costs of £24,685,000 and £315,000 respectively were disclosed as "Debt due within one year". Refer also to "Basis of preparation" note.

 

 

END

 

 

FR GGUBUBUPBGCA